It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In mice, time of day strongly influences lethality in response to LPS, with survival greatest at the beginning compared to the end of the light cycle. Here we show that feeding, rather than light, controls time-of-day dependent LPS sensitivity. Mortality following LPS administration is independent of cytokine production and the clock regulator BMAL1 expressed in myeloid cells. In contrast, deletion of BMAL1 in hepatocytes globally disrupts the transcriptional response to the feeding cycle in the liver and results in constitutively high LPS sensitivity. Using RNAseq and functional validation studies we identify hepatic farnesoid X receptor (FXR) signalling as a BMAL1 and feeding-dependent regulator of LPS susceptibility. These results show that hepatocyte-intrinsic BMAL1 and FXR signalling integrate nutritional cues to regulate survival in response to innate immune stimuli. Understanding hepatic molecular programmes operational in response to these cues could identify novel pathways for targeting to enhance endotoxemia resistance.
Time of day influences immune responses and lethality in response to LPS, with survival greatest at the beginning compared to the end of the light cycle. Here the authors show that feeding, rather than light, controls time-of-day dependent LPS sensitivity through the liver clock and hepatic FXR signalling.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 National Institutes of Health, Immunoregulation Section, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165); Trinity College Dublin, Department of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Dublin, Ireland (GRID:grid.8217.c) (ISNI:0000 0004 1936 9705)
2 National Institutes of Health, Laboratory of Mitochondrial Biology and Metabolism, National Heart Lung and Blood Institute (NHLBI), Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165); Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Departamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126)
3 National Institutes of Health, Immunoregulation Section, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
4 NIH, Biodata Mining and Discovery Section, Office of Science and Technology, NIAMS, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
5 National Institutes of Health, Lymphocyte Cell Biology Section, Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
6 National Institutes of Health, Laboratory of Mitochondrial Biology and Metabolism, National Heart Lung and Blood Institute (NHLBI), Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
7 National Institutes of Health, Laboratory of Metabolism, National Cancer Institute (NCI), Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)